Pasvolsky, O., Grajales-Cruz, A., Hansen, D., Feng, L., Dima, D., Afrough, A., Shain, K., Banerjee, R., Zanwar, S., Anwer, F., Hosoya, H., Davis, J., Sannareddy, A., Lee, L., Ye, J. C., Puglianini, O. A. C., Neupane, K., Richards, T., Krishnan, A., Biran, N., Herr, M., Raza, S., Shune, L., Bal, S., Fogel, L., Rana, M., Hassan, H., Ali, H. M., Baz, R., Joiner, L., Ferreri, C., Green, K., Janakiram, M., Varga, C., Fortuna, G. G., Gaballa, M., Julian, K., Mikkilineni, L., Bhurtel, E., Atrash, S., Zolotov, E., Sborov, D., Voorhees, P., Goel, U., Anderson, L., Portuguese, A., Lee, H., Khouri, J., Sidana, S., Costa, L., Patel, K., Lin, Y. (2025). Talquetamab for relapsed/refractory multiple myeloma : Real-world outcomes from the US multiple myeloma immunotherapy consortium. Blood. https://doi.org/10.1182/blood-2025-137